sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Files Form 8.3 on Mural Oncology plc Holdings
The Vanguard Group, Inc. has filed a Form 8.3 concerning its interests in Mural Oncology plc. As of November 17, 2025, The Vanguard Group holds 288,843 ordinary shares, representing a 1.67% stake, in the company. This disclosure complies with the Irish Takeover Panel Act, 1997, and demonstrates transparency in their dealings.
Vanguard's filing indicates a recent purchase of 112 ordinary shares at $2.08 per unit. No details on cash-settled or stock-settled derivatives were reported, highlighting a straightforward equity interest. The document confirms the absence of indemnity, option arrangements, or understandings that might influence future dealings or voting rights.
The filing underscores Vanguard's compliance with disclosure regulations, providing an open view of its positions related to Mural Oncology plc.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.